Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

New NLRP3 inflammasome inhibitors discovered at NodThera

Aug. 12, 2020

Daiichi Sankyo patents new SIRT6 activators

Aug. 7, 2020

Honest placebos change brain potentials

Aug. 4, 2020

Kyorin Pharmaceutical discloses new 15-hydroxyprostaglandin dehydrogenase inhibitors

July 30, 2020

Suzhou Zelgen Biosciences identifies new MAP3K5 inhibitors

July 29, 2020

Huihan Medical Technologies discloses new Wnt signaling inhibitors

July 14, 2020

New galectin-3 inhibitors discovered at Bristol-Myers Squibb

July 1, 2020

The bow ties that bind

June 25, 2020

Liver-derived protein helps lung, kidney repair

June 23, 2020

New targets and "molecular beacon" give new insights into senescence

June 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...